Biolidics Limited (SGX: 8YY)
Singapore
· Delayed Price · Currency is SGD 0.0100
0.00 (0.00%)
At close: Nov 13, 2024
Biolidics Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | -2.95 | -2.49 | -9.37 | -5.98 | -4.65 | -4.81 | Upgrade
|
| Depreciation & Amortization | 0.15 | 0.24 | 1.18 | 1.25 | 1 | 0.64 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.01 | - | 0.01 | -0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 4.04 | - | 0.01 | 0.13 | Upgrade
|
| Stock-Based Compensation | 0.05 | - | -0.07 | 0.11 | 1.95 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.07 | 0.08 | 0.08 | - | 0.02 | 0 | Upgrade
|
| Other Operating Activities | 0.14 | 0.21 | 0.89 | 0.38 | 0.11 | 0.06 | Upgrade
|
| Change in Accounts Receivable | 0.05 | 0.36 | -0.47 | 0.08 | 0 | 0.23 | Upgrade
|
| Change in Inventory | 0.03 | -0.14 | 0.12 | -0.39 | -0.79 | -0.35 | Upgrade
|
| Change in Accounts Payable | 0 | -0.07 | 0.01 | -0.06 | -0.42 | 0.21 | Upgrade
|
| Change in Unearned Revenue | -0.04 | -0.11 | 0.07 | -0.1 | 0.06 | -0.11 | Upgrade
|
| Change in Other Net Operating Assets | 0.34 | -0.05 | 0.45 | 0.09 | 0.27 | -0.54 | Upgrade
|
| Operating Cash Flow | -2.03 | -1.97 | -3.06 | -4.64 | -2.43 | -4.56 | Upgrade
|
| Capital Expenditures | - | - | -0.03 | -0.43 | -0.32 | -0.56 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0 | - | 0.02 | Upgrade
|
| Cash Acquisitions | -2.14 | -2.69 | - | -0.3 | -0.09 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.06 | -0.13 | -0.12 | -0.12 | Upgrade
|
| Other Investing Activities | - | - | 0.1 | - | - | - | Upgrade
|
| Investing Cash Flow | -2.14 | -2.69 | 0.01 | -0.86 | -0.54 | -0.67 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 5 | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.32 | -1.29 | -1.15 | -0.6 | -0.26 | Upgrade
|
| Net Debt Issued (Repaid) | 0.21 | -1.32 | -1.29 | -1.15 | 4.4 | -0.26 | Upgrade
|
| Issuance of Common Stock | 2.18 | 1.17 | 5.7 | - | 3.13 | - | Upgrade
|
| Other Financing Activities | -0.13 | -0.06 | -0.22 | - | -0.03 | - | Upgrade
|
| Financing Cash Flow | 2.25 | -0.2 | 4.18 | -1.15 | 7.5 | -0.26 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.07 | 0.01 | -0.05 | -0.06 | 0.11 | 0.02 | Upgrade
|
| Net Cash Flow | -1.84 | -4.85 | 1.07 | -6.71 | 4.64 | -5.47 | Upgrade
|
| Free Cash Flow | -2.03 | -1.97 | -3.1 | -5.07 | -2.76 | -5.12 | Upgrade
|
| Free Cash Flow Margin | -157.96% | -144.45% | -116.38% | -217.65% | -29.72% | -335.58% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.01 | -0.02 | Upgrade
|
| Cash Interest Paid | 0.05 | 0.07 | 0.11 | 0.14 | 0.09 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -3.25 | -4.84 | 2.14 | -2.98 | -0.93 | -3.22 | Upgrade
|
| Unlevered Free Cash Flow | -3.21 | -4.77 | 2.25 | -2.85 | -0.85 | -3.22 | Upgrade
|
| Change in Net Working Capital | 1.55 | 3.47 | -4.86 | -0.11 | 0.71 | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.